Company news

Share this article:
GlaxoSmithKline will put a legal charge of $400 million on its fourth quarter books, related to an ongoing off-label marketing investigation initiated by the US Attorney's office in Colorado. The investigation is probing GSK's marketing and promotional practices on several products between 1997 and 2004.
Mead Johnson Nutrition, a unit of Bristol-Myers Squibb, will spin-off from the company with an initial public offering of 28.75 million shares. The company hopes to raise as much as $690 million through the offering.
PeerPoint Medical Education Institute has reorganized as an independent company no longer tied to MedPoint Communications. The ACCME-accredited provider, which focuses on performance/quality improvement CME initiatives, is spinning off ahead of an ACCME edict that goes into effect this August requiring strict separation of providers from companies which handle promotion for drug and device manufacturers. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.